Similar articles

• The use of synthetic luteinizing hormone-releasing hormone in induction of ovulation.

  Acosta AA, Buttram VC Jr, Malinak LR, Besch PK, Franklin RR. Acosta AA, et al. Fertil Steril. 1975 Dec;26(12):1173-7. doi: 10.1016/s0015-0282(16)41530-x. Fertil Steril. 1975. PMID: 803167
• Antagonists of bombesin/gastrin-releasing peptides as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.

  Pinski J, Halmos G, Szepeshazi K, Schally AV. Pinski J, et al. Cancer. 1993 Dec 1;72(11):3263-70. doi: 10.1002/1097-0142(19931201)72:11<3263::aid-cncr2820721122>3.0.co;2-v. Cancer. 1993. PMID: 8242552
• Effect of exogenous luteinizing hormone-releasing hormone on hypothalamic pituitary function in women with ovarian failure.

  Albert JL, Kubik CJ, Archer DF. Albert JL, et al. Fertil Steril. 1987 Aug;48(2):198-203. doi: 10.1016/s0015-0282(16)59342-x. Fertil Steril. 1987. PMID: 3301416
• Luteinizing hormone-releasing hormone agonists in premenopausal hormone receptor-positive breast cancer.

  Tan SH, Wolff AC. Tan SH, et al. Clin Breast Cancer. 2007 Feb;7(6):455-64. doi: 10.3816/CBC.2007.n.002. Clin Breast Cancer. 2007. PMID: 17386122 Review.
• [History of clinical studies on hypothalamic hormone analogs in Mexico].

  Schally AV, González Bárcena D. Schally AV, et al. Gac Med Mex. 2006 Jul-Aug;142(4):315-25. Gac Med Mex. 2006. PMID: 17022307 Review. Spanish.